How sponsors choose a CDMO and what they need to see

A biotech sponsor is about to hand its molecule to a building it has never been inside.

That is the tension in choosing a CDMO. The sponsor carries the risk and the CDMO does the work. And the first impression usually comes from a website, a slide deck and a capabilities sheet that look like everyone else's.

In North Carolina the competition is easy to see. Fujifilm built its Holly Springs plant around eight 20,000 liter bioreactors, and it signed a 10 year agreement with Regeneron valued at over $3 billion, NCBiotech reported in April 2025.

The sponsor is buying an extension of its own plant

FDA says so in writing. Its rule at 21 CFR 200.10(b) says the agency "regards extramural facilities as an extension of the manufacturer's own facility."

FDA's 2016 guidance on quality agreements keeps the owner's quality unit "ultimately responsible" for CGMP on products made under contract, and says the agreement should let the owner audit the contract site.

So whoever reads your proposal is choosing someone whose mistakes become theirs.

What gets a CDMO cut

Industry Standard Research (ISR) asked 100 respondents in the third quarter of 2025 for the single main reason a CDMO would lose a bid. More of them named regulatory violations or FDA Form 483 observations than anything else, at 26 percent. High cost was second at 20 percent, PharmaSource reported in March 2026.

Asked for their top three reasons, 52 percent included missing the required timeline. Lack of responsiveness made 27 percent of top three lists.

A sponsor can check part of this before you ever talk. FDA posts final inspection classifications, from No Action Indicated to Official Action Indicated, on its Data Dashboard and updates them weekly. Assume they have looked.

What they need to see

Your record, said plainly. If you had a Form 483, the sponsor may already know. Have your head of quality explain what was found, what changed and how you know it held. A calm, specific answer does more than a page of reassurance.

The suite that fits their molecule. The scale, the modality and the room their program would run in, and when it is open.

The people on their program. The project manager, the tech transfer lead, the QA reviewer who will see their batch records. Sponsors pick teams as much as plants.

How you handle a bad day. Every plant has deviations. Show how one gets raised, investigated and closed, and who calls the sponsor.

How fast you answer. Timeline and responsiveness both showed up in the ISR numbers. A sponsor starts judging that from the first email.

Where video fits, and where it does not

We make video, so here is the honest version. No sponsor picks a CDMO from a film. The audit, the quality agreement and the technical review decide.

What video can do is get you onto the shortlist and make the visit count. A sponsor's team includes scientists, QA, supply chain and finance, and most of them will never fly in. A short film of the suite, the team and your quality lead lets all of them see the same thing before the first call.

Often the gap is belief, not awareness. We saw that with Naturally Nectar, a Triad health beverage maker. A woman in senior services had known the product for a long time and had met the founder. She bought her first bottle after watching a two minute video on LinkedIn, and called it her light bulb moment. A sponsor who already knows your name can be in the same spot.

The film also needs a job. We once made a beautiful commercial that sat on a client's website, unused. When we filmed again around who was watching and what they needed to hear, those videos helped close three deals within two months. A facility flythrough set to music is that first commercial. More on why your buyer can't follow what you do.

Filming it without a deviation

The most convincing footage is inside the classified areas, which is exactly where QA does not want a crew. We have not filmed inside a biologics plant. We have filmed a working dental lab, Apex Dental Laboratory Group. In any regulated space our rule is the same. Gowning and lab rules apply to us like everyone else, they are sorted before shoot day, and nothing is published without your approval. More on our medical and dental lab video work.

For a CDMO that means following your gowning procedure or shooting through viewing windows, keeping screens and batch records out of frame, and letting QA approve the cut.